Microfluidics News and Research

RSS

University of Pittsburgh to honor Synthetic Genomics CEO with Dickson Prize

The scientist-entrepreneur who led efforts to map the first draft of the human genome as well as the complete diploid genome and to construct the first synthetic bacterium has been named this year's recipient of the University of Pittsburgh's Dickson Prize in Medicine.

28 Jul 2011

New technologies could bring innovative sensors, devices for 'lab-on-a-chip' applications

Researchers are developing new technologies that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses and DNA for a range of potential applications, from drug manufacturing to food safety.

6 Jul 2011

Rheonix to receive U.S. patent for powerful microfluidic platform

Rheonix, Inc., developer of the Rheonix CARD system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, "Microfluidic Chips and Assay Systems," and on April 13, 2011 it allowed Patent Application Number 11/594,444, "Microfluidic Systems," to the Company.

3 Jun 2011

Cellix Inks OEM supply agreement with Cell Biolabs

Cellix are pleased to announce the signing of an OEM manufacture and supply agreement with Cell Biolabs on a range of microfluidic biochips and accessories for cell-based assays. Cell-Biolabs, based in San Diego, CA, will supply the biochips from their current Cell-Based Assay product range thereby diversifying their product portfolio and entering into the microfluidics field.

23 May 2011

Stony Brook University CFB establishes Biotechnology Commercialization Fund

The Center for Biotechnology (CFB) at Stony Brook University has established the Biotechnology Commercialization Fund to accelerate the development of promising biomedical technologies emerging from Stony Brook University.

21 May 2011

Serpin-2 molecule may be a perfect target for preventing mosquito's immunity

Mosquitoes are becoming more resistant to current pesticides. That's troubling to Kansas State University biologist Kristin Michel, as it means malaria and other mosquito-borne diseases will continue spreading. A recent grant from the National Institutes of Health may change all that.

18 May 2011

Fluidigm announces availability of genetic assays and primers for integrated fluidic circuit technology

Fluidigm Corporation today announced the availability of assays and primers optimized for the company's integrated fluidic circuit technology.

10 May 2011

Caliper first quarter revenue increases 25% to $35.8 million

Caliper Life Sciences, Inc., today reported its financial results for the first quarter of 2011. First quarter revenue increased to $35.8 million, or 25%, from $28.7 million in the same period of 2010.

2 May 2011

Magnetic 'nanobeads' help detect chemical and biological agents

Researchers at Oregon State University have found a way to use magnetic "nanobeads" to help detect chemical and biological agents, with possible applications in everything from bioterrorism to medical diagnostics, environmental monitoring or even water and food safety.

27 Apr 2011

Alnylam, Precision NanoSystems enter collaboration for discovery of novel small lipid nanoparticles

Precision NanoSystems, Inc. and Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the two companies have formed an exclusive collaboration focused on the discovery and development of novel lipid nanoparticles, known as small lipid nanoparticles ("sLNPs"), using microfluidics technology.

From Precision NanoSystems Inc. 20 Apr 2011

Shrink Nanotechnologies to acquire Nanopoint

Shrink Nanotechnologies, Inc., an innovative high technology company, announced today that it has executed a binding letter of intent to acquire 100% of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.

12 Apr 2011

Caliper's CDAS unit enters cancer research collaboration with Denver-based CHI

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems.

6 Apr 2011

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the launch of XenoLight RediJect COX-2 Probe, a novel fluorescent imaging agent for pre-clinical research that specifically detects the cyclooxygenase-2 biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications.

5 Apr 2011

Study develops new approaches for sorting out complexities of cancer cells

New drugs that specifically target the mutated genes responsible for cancer growth have shown great success in extending the lives of patients, with far fewer side effects than conventional anti-cancer therapies. Unfortunately, many patients become resistant to these drugs due to secondary mutations.

25 Mar 2011

Linköping doctor invents electroosmotic pump that can be placed in microfluidic chip

Advances in medical diagnostic technology will likely allow individuals to perform preliminary medical diagnoses themselves, in their own home, in the future.

24 Mar 2011

BUSM scientists identify new biomarker and melanoma treatment target

Researchers at Boston University School of Medicine, in collaboration with Johns Hopkins University, have identified a potential new biomarker and therapeutic target for melanoma.

18 Mar 2011

CALP, HistoRx collaborate to co-develop new generation of tissue-based imaging solutions

Caliper Life Sciences, Inc. and HistoRx, Inc., today announced a collaboration to co-develop a new generation of tissue-based imaging and analysis solutions, based on immuno-fluorescence, that will deliver accurate, quantitative, and reproducible measurements of proteins in tissue samples.

11 Mar 2011

Caltech students receive Lemelson-MIT Prize for innovative disease diagnostic technology works

California Institute of Technology graduate student Guoan Zheng is the recipient of the 2011 $30,000 Lemelson-MIT Caltech Student Prize.

10 Mar 2011

Study shows how individual cells behave during blood vessel formation

Biologists tend to look at cells in bulk, observing them as a group and taking the average behavior as the norm - the assumption is that genetically identical cells all behave the same way.

8 Mar 2011

Wako i30 Immunoanalyzer incorporating Caliper's microfluidic LabChip technologies receives 510(k) clearance

Caliper Life Sciences, Inc. today announced that its licensee Wako Pure Chemical Industries, through its Wako Diagnostics division, has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its uTASWako® i30 Immunoanalyzer and AFP-L3 and DCP Assays, which are used to assess liver cancer risk in patients with chronic liver disease.

4 Mar 2011